Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives

F Merloni, M Palleschi, C Gianni, M Sirico… - Clinical & Experimental …, 2024 - Springer
Metastatic breast cancer (MBC) is still an incurable disease, which eventually develops
resistance mechanisms against systemic therapies. While most patients experience …

Protective effect of melatonin against radiobiological damage in the brain of rats exposed to low and high dose rate radiotherapy

OV Gul, K Parlak, FHY Aydemir, I Babalıoglu… - Radiation Physics and …, 2024 - Elsevier
This study aimed to investigate the radioprotective effect of melatonin (MLT) on brain
damage in rats exposed to low and high dose rate radiotherapy. The dose rates of 10 MV …

Differences between Survival Rates and Patterns of Failure of Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma Who Received Single-Fraction …

TV Schrand, AJ Iovoli, ND Almeida, H Yu, N Malik… - Cancers, 2024 - mdpi.com
Simple Summary Stereotactic body radiotherapy (SBRT) offers a highly conformal
tumoricidal dose of radiation and is an effective treatment for early stage non-small cell lung …

Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral …

MD Shanker, AP Cavazos, J Li, TH Beckham… - Radiotherapy and …, 2024 - Elsevier
Introduction Sarcoma spinal metastases (SSM) are particularly difficult to manage given their
poor response rates to chemotherapy and inherent radioresistance. We evaluated outcomes …

Efficient quality assurance for isocentric stability in stereotactic body radiation therapy using machine learning

S Salahuddin, SA Buzdar, K Iqbal, MA Azam… - … Physics and Technology, 2024 - Springer
This study aims to predict isocentric stability for stereotactic body radiation therapy (SBRT)
treatments using machine learning (ML), covers the challenges of manual assessment and …

ABLATIVE Radiation Therapy for Breast Cancer: The Time Has Come for Innovation

SF Shaitelman - International Journal of Radiation Oncology, Biology …, 2025 - redjournal.org
In the article accompanying this editorial, investigators of the ABLATIVE clinical trial present
5-year follow-up data from a prospective, phase 2 trial of preoperative partial breast …